TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 119 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2015. The put-call ratio across all filers is 4.19 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $555,000 | -21.1% | 6,500 | 0.0% | 0.02% | -18.5% |
| Q1 2019 | $703,000 | +225.5% | 6,500 | +195.5% | 0.03% | +285.7% |
| Q3 2018 | $216,000 | -62.5% | 2,200 | -60.0% | 0.01% | -61.1% |
| Q4 2017 | $576,000 | -7.1% | 5,500 | 0.0% | 0.02% | -5.3% |
| Q3 2017 | $620,000 | +0.6% | 5,500 | 0.0% | 0.02% | +5.6% |
| Q2 2017 | $616,000 | +62.5% | 5,500 | +111.5% | 0.02% | +63.6% |
| Q2 2016 | $379,000 | +1.9% | 2,600 | 0.0% | 0.01% | -15.4% |
| Q1 2016 | $372,000 | -7.5% | 2,600 | 0.0% | 0.01% | -7.1% |
| Q4 2015 | $402,000 | +8.1% | 2,600 | 0.0% | 0.01% | +16.7% |
| Q3 2015 | $372,000 | -16.4% | 2,600 | -16.1% | 0.01% | 0.0% |
| Q2 2015 | $445,000 | +1.8% | 3,100 | 0.0% | 0.01% | +9.1% |
| Q1 2015 | $437,000 | -4.8% | 3,100 | 0.0% | 0.01% | -8.3% |
| Q4 2014 | $459,000 | -3.8% | 3,100 | 0.0% | 0.01% | +9.1% |
| Q3 2014 | $477,000 | +9.7% | 3,100 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $435,000 | – | 3,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
| ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
| Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
| Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
| Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
| BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
| FORT, L.P. | 9,672 | $730,000 | 0.14% |
| CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
| ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |